Two Stanford grads raise $11M to build a noninvasive wearable for hormone tracking

2026-06-17 · Source: TechCrunch · Field: Health & Wellbeing — Medical Devices & Health Technology, Clinical Care & Medical Practice · Depth: Fundamental Awareness, short

Summary

Clair Health, a startup co-founded by Stanford graduates Jenny Duan and Abhinav Agarwal, has secured \$11.6 million in funding, led by Khosla Ventures, to develop a noninvasive wearable device for comprehensive hormone tracking in women. This device integrates 10 biosensors, including a novel biomagnetic sensor, to continuously monitor hormonal changes, inflammation, bloating, and energy levels across all four menstrual cycle phases. The company also utilizes voice-based onboarding and a proprietary AI trained to analyze voice biomarkers for cycle phase classification. Clair Health aims to provide insights into cycle irregularities, perimenopause, and hormonal fluctuations, offering data to users and healthcare providers. The device is currently in closed beta, with preorders available for shipping in November at \$369, plus a \$9.99 monthly subscription.

Key takeaway

For AI Product Managers developing health wearables, consider integrating novel biosensors beyond standard gyroscopes and optical sensors to capture complex physiological data like hormones. Your product strategy should explore voice-based AI for personalized onboarding and biomarker analysis, as demonstrated by Clair Health's approach to women's health. This can differentiate offerings and provide deeper, continuous insights, moving beyond symptom logging to real-time, actionable data for users and clinicians.

Key insights

Clair Health offers a noninvasive wearable and AI for continuous, multi-biomarker hormone tracking to empower women's health understanding.

Principles

• Hormonal health requires more than standard health tracker sensors.
• Voice-based data collection can personalize health marker understanding.
• Continuous cycle phase monitoring yields deeper insights.

Method

A wearable with 10 biosensors, including a novel biomagnetic sensor, continuously evaluates biomarkers. Voice-based onboarding and proprietary AI analyze voice biomarkers for cycle phase classification, supported by EHR data partnerships.

In practice

• Deploy novel biomagnetic sensors for real-time hormonal insights.
• Integrate AI with voice analysis for personalized health tracking.
• Generate comprehensive hormonal data for healthcare provider consultations.

Topics

• Wearable Technology
• Hormone Tracking
• Women's Health
• AI Biomarkers
• Biosensors
• Startup Funding

Best for: Entrepreneur, Investor, AI Product Manager

Related on AIssential

• Personalized and Context-Aware Transformer Models for Predicting Post-Intervention Physiological Responses from Wearable Sensor Data — Transformer models can predict personalized physiological responses to stress interventions using wearable sensor data.
• The most interesting health and wellness tech I've seen at CES 2026 so far — CES 2026 showcases diverse consumer health tech, from allergy detection to smart wearables and light therapy.
• Smart ring maker Oura files to go public — Oura's IPO filing highlights the growth of specialized wearable health tech and targeted AI.
• An Exploratory Study of Blood Glucose Estimation from Photoplethysmography Signals using Machine Learning — Machine learning models can potentially estimate blood glucose non-invasively from smartwatch Photoplethysmogram (PPG) signals.
• Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity — A health awakening is driving demand for peptides and advanced bio-interventions, emphasizing individual responsibility and future bio-communication.
• The Fitbit Air is a good wearable weighed down by a chatty AI "coach" — A minimalist wearable's utility is hampered by an overly chatty, sometimes inaccurate, AI health coach.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by TechCrunch.